https://www.voxmarkets.co.uk/articles/alastair-smith-of-avacta-successful-completion-of-fourth-dose-escalation-in-ava6000-phase-1-clinical-study-5e35ec7/
A worthwhile listen – interview with the Avacta CEO post today’s announcement
